- Home
- TSHA vs OSBC Comparison
TSHA vs OSBC Comparison
Compare TSHA & OSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- OSBC
- Stock Information
- Founded
- TSHA 2019
- OSBC 1981
- Country
- TSHA United States
- OSBC United States
- Employees
- TSHA N/A
- OSBC N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- OSBC Major Banks
- Sector
- TSHA Health Care
- OSBC Finance
- Exchange
- TSHA Nasdaq
- OSBC Nasdaq
- Market Cap
- TSHA 728.4M
- OSBC 770.5M
- IPO Year
- TSHA 2020
- OSBC N/A
- Fundamental
- Price
- TSHA $2.32
- OSBC $18.24
- Analyst Decision
- TSHA Strong Buy
- OSBC Buy
- Analyst Count
- TSHA 5
- OSBC 5
- Target Price
- TSHA $8.20
- OSBC $20.00
- AVG Volume (30 Days)
- TSHA 3.7M
- OSBC 209.3K
- Earning Date
- TSHA 08-11-2025
- OSBC 07-16-2025
- Dividend Yield
- TSHA N/A
- OSBC 1.35%
- EPS Growth
- TSHA N/A
- OSBC N/A
- EPS
- TSHA N/A
- OSBC 1.83
- Revenue
- TSHA $7,224,000.00
- OSBC $275,720,000.00
- Revenue This Year
- TSHA N/A
- OSBC $21.45
- Revenue Next Year
- TSHA N/A
- OSBC $12.41
- P/E Ratio
- TSHA N/A
- OSBC $9.69
- Revenue Growth
- TSHA N/A
- OSBC 2.88
- 52 Week Low
- TSHA $1.05
- OSBC $14.14
- 52 Week High
- TSHA $3.31
- OSBC $19.46
- Technical
- Relative Strength Index (RSI)
- TSHA 41.03
- OSBC 67.80
- Support Level
- TSHA $2.29
- OSBC $17.09
- Resistance Level
- TSHA $2.48
- OSBC $17.86
- Average True Range (ATR)
- TSHA 0.17
- OSBC 0.38
- MACD
- TSHA -0.05
- OSBC 0.09
- Stochastic Oscillator
- TSHA 9.21
- OSBC 96.18
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About OSBC Old Second Bancorp Inc.
Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The Company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.